CAS: 34352-59-5 - 1-methylpiperazine dihydrochloride
Formula:C5H14Cl2N2
InChI:InChI=1/C5H12N2.2ClH/c1-7-4-2-6-3-5-7;;/h6H,2-5H2,1H3;2*1H
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
1-Methylpiperazine dihydrochloride REF: IN-DA003EISCAS: 34352-59-5 | 98% | 26.00 €~153.00 € | Thu 12 Dec 24 | |
1-Methylpiperazine dihydrochloride REF: 10-F320129CAS: 34352-59-5 | 98.0% | To inquire | Fri 27 Dec 24 | |
1-Methylpiperazine Dihydrochloride REF: TR-M326430CAS: 34352-59-5 | - - - | 212.00 €~470.00 € | Wed 22 Jan 25 | |
1-Methylpiperazine dihydrochloride REF: 3D-JBA35259CAS: 34352-59-5 | Min. 95% | - - - | Discontinued product |
1-Methylpiperazine dihydrochloride
CAS:34352-59-5
Formula:
C5H14Cl2N2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
173.0841
Ref: IN-DA003EIS
1g | 26.00 € | ||
5g | 34.00 € | ||
10g | 50.00 € | ||
25g | 61.00 € | ||
100g | 153.00 € |
Estimated delivery in United States, on Thursday 12 Dec 2024
1-Methylpiperazine dihydrochloride
CAS:34352-59-5
Purity:
98.0%
Color and Shape:
Solid
Molecular weight:
173.0800018310547
Ref: 10-F320129
1g | 20.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
1-Methylpiperazine Dihydrochloride
Controlled ProductCAS:34352-59-5
Applications 1-Methylpiperazine is used in the preparation of 2-(4-Methyl-1-piperazinylmethyl)acrylophenone(MPMAP), an antimicrotubular drug. References Mallevais, M.L. …
Formula:
C5H14Cl2N2
Color and Shape:
Neat
Molecular weight:
173.08
Ref: TR-M326430
1g | 212.00 € | ||
10g | 470.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025
1-Methylpiperazine dihydrochloride
CAS:34352-59-5
1-Methylpiperazine dihydrochloride is a serotonin reuptake inhibitor that belongs to the group of experimental drugs. …
Formula:
C5H12N2·2HCl
Purity:
Min. 95%
Molecular weight:
173.08 g/mol
Ref: 3D-JBA35259
5g | Discontinued | Request information | |
10g | Discontinued | Request information | |
25g | Discontinued | Request information | |
50g | Discontinued | Request information | |
100g | Discontinued | Request information |